What is Neuroendovascular Coil Market?
Neuroendovascular coils are mainly used for the treatment of brain aneurysms and some other vascular abnormalities. These coils are the prescription devices that are implanted by a specialized physician into the aneurysm sac so as to obstruct the blood flow and thereby promote clotting. As aneurysms that are treated with the coils may have some residual filling or have the chances to reappear, thereby putting the patient at high risk for late hemorrhage, therefore follow-up imaging is performed whenever necessary post the procedure. Digital subtraction angiography (DSA) has also been a traditional method that was used for the purpose of the imaging of aneurysms after the coiling procedure. This would in turn help by sealing the aneurysm, encouraging blood clotting around the coils, and hence reducing the pressure on its outer wall. The coiling treatment is generally performed under the common anesthesia by a neurosurgeon or an interventional neuroradiologist with the help of using the fluoroscopic imaging guidance. The coil is left behind and is placed permanently inside the aneurysm. Coiling is implemented for both the ruptured and unruptured aneurysms. The neuroendovascular coils are used as a substitute for effective treatment of the surgical clipping in an aneurysm. This neuroendovascular coiling further helps in the prevention of subarachnoid hemorrhage that may lead to strokes, some major complications, and sometimes may even cause death.
The market study is being classified by Type (Guglielmi Detachable Coils (GDC) and Matrix Coils), by Application (Aneurysm-Embolization, Malformation-Embolization, Ischemic stroke-Revascularization and Stenosis-Revascularization) and major geographies with country level break-up.
Stryker Corporation (United States), Johnson & Johnson (United States), MicroVention Inc. (United States), Medtronic (Ireland), Blockade Medical (United States), Penumbra (United States), Cardinal Health (United States), Boston Scientific (United States), Cook Medical Inc. (United States) and Terumo Corporation (Japan) are some of the key players profiled in the study.
The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products, and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Neuroendovascular Coil market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Neuroendovascular Coil market by Type, Application and Region.
On the basis of geography, the market of Neuroendovascular Coil has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Growing Health Care Industry
- An Aging Population Which Consequently Would Lead To an Increased Patient Population
- High Incidence of Brain Aneurysms
Market Trend
- Growing Awareness about Health in the Developing Countries
- Increase in Success Rates of Neuroendovascular Coiling For the Treatment of Aneurysms
Restraints
- Risk of Complication in Neurovascular Procedures
- Side Effects of the Coiling Procedure
Opportunities
- Increasing Investments by the Governmental Bodies In Order To Enhance Healthcare Facilities
- Technological Advancements in the Healthcare Industry
Challenges
- Stiff Competition among Existing Neuroendovascular Coil Manufacturers
Key Target Audience
Manufacturers of Neuroendovascular Coil, Suppliers and Distributors of Neuroendovascular Coil, End-Users, Potential Investors, Market Research Firms, Regulatory Bodies and Others